Clinical trial
Monitoring the Effectiveness and Safety of Antihypertensive Therapy With a Fixed-Dose Combination of Perindopril and Amlodipine in Patients With Uncontrolled Essential Hypertension
NCT07876895 is registered in ClinicalTrials.gov with Bosnalijek D.D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring the Effectiveness and Safety of Antihypertensive Therapy With a Fixed-Dose Combination of Perindopril and Amlodipine in Patients With Uncontrolled Essential Hypertension
- Lead sponsor
- Bosnalijek D.D
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 16, 2025
- Completion date
- October 31, 2026
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.